Département de Neuropédiatrie, CHU de Montpellier, Hôpital Gui de Chauliac, 34295, Montpellier, France; King Abdulaziz University, Department of Pediatrics, 21589, Jeddah, Saudi Arabia.
Département de Neuropédiatrie, CHU de Montpellier, Hôpital Gui de Chauliac, 34295, Montpellier, France.
Arch Pediatr. 2022 Apr;29(3):230-235. doi: 10.1016/j.arcped.2022.01.004. Epub 2022 Jan 31.
The aim of this retrospective study is to explore the prognostic value of different contrast enhancement imaging patterns in childhood Guillain-Barré syndrome by comparing the clinical, laboratory, and therapeutic outcomes.
We included a total of 37 patients who were diagnosed and followed up by a pediatric neurology team at Montpellier University Hospital between 2000 and 2016. All images were reinterpreted by the first author and a senior pediatric neuroradiology staff member in two different sessions; in the case of disagreement, the expert's reading was considered.
The study group comprised 22 (59.5%) boys and 15 (40.5%) girls. The age ranged from 1.5 year to 14.8 years. Muscle weakness was present in 33 (89.2%) patients. Cranial nerves involvement was observed in 22 (59.5%) patients, while 29 (78.4%) patients had albuminocytological dissociation. In 27 (73%) patients, contrast enhancement or thickening of the lumbosacral nerve roots was found. Simultaneous spinal nerve root and cranial nerve enhancement was noted in five (17.2%) patients, while isolated cranial nerve enhancement was identified in three (10.3%) patients. Clinical and radiological cranial nerve involvement was found in seven (18.9%) patients, while isolated clinical cranial nerves involvement occurred in 13 (35.1%) patients. No significant correlation between different magnetic resonance imaging (MRI) enhancement patterns and short-term or long-term outcomes was found in our cohort.
Contrast-enhanced brain and spinal MRI is a sensitive and recommended supportive test for diagnosing acute inflammatory polyradiculopathy in children. Its predictive value for clinical, and therapeutic outcomes in the short or long term has not yet been proved.
本回顾性研究旨在通过比较临床、实验室和治疗结果,探讨不同对比增强成像模式在儿童吉兰-巴雷综合征中的预后价值。
我们共纳入了 37 例 2000 年至 2016 年期间在蒙彼利埃大学医院由儿科神经病学团队诊断和随访的患者。所有图像均由第一作者和一位资深儿科神经放射科工作人员在两个不同的时段重新解读;如果意见不一致,则以专家的解读为准。
研究组包括 22 名(59.5%)男孩和 15 名(40.5%)女孩。年龄范围为 1.5 岁至 14.8 岁。33 例(89.2%)患者存在肌无力。22 例(59.5%)患者出现颅神经受累,29 例(78.4%)患者存在白蛋白细胞分离。27 例(73%)患者腰骶神经根存在对比增强或增厚。5 例(17.2%)患者同时存在脊髓神经根和颅神经增强,3 例(10.3%)患者存在孤立性颅神经增强。7 例(18.9%)患者存在临床和影像学颅神经受累,13 例(35.1%)患者存在孤立性临床颅神经受累。在我们的队列中,不同磁共振成像(MRI)增强模式与短期或长期结局之间未发现显著相关性。
对比增强脑和脊髓 MRI 是诊断儿童急性炎症性多神经根病的一种敏感且推荐的辅助检查方法。其对短期或长期临床和治疗结局的预测价值尚未得到证实。